Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Vmn1r160 Inhibitors

Vmn1r160 inhibitors represent a class of chemical compounds that selectively target the Vmn1r160 receptor, which belongs to the Vomeronasal 1 receptor family. This family of receptors is primarily involved in pheromone detection, contributing to interspecies and intraspecies communication in certain animals. Vmn1r160, as a G-protein-coupled receptor (GPCR), participates in signaling pathways by binding specific ligands and triggering a cascade of intracellular responses. Inhibitors of Vmn1r160 are designed to modulate these interactions, preventing the receptor from being activated by its ligands. Such modulation can provide researchers with critical insight into the functional role of Vmn1r160 in sensory perception, olfaction, and the overall understanding of how chemosensory receptors influence behavior in animals.

The structure and function of Vmn1r160 inhibitors vary widely, but they often share chemical characteristics that allow them to interact with the active site of the receptor. These inhibitors may contain hydrophobic or polar regions that facilitate binding to Vmn1r160, blocking the natural ligand from initiating a signaling event. The specificity of these inhibitors is of significant interest in receptor biochemistry, as it enables the selective targeting of Vmn1r160 without affecting other receptors in the vomeronasal system. Research involving Vmn1r160 inhibitors contributes to a broader understanding of GPCR mechanisms, ligand-receptor specificity, and receptor regulation in non-human species, where the vomeronasal system plays a pivotal role in environmental sensing and communication.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

NF449

627034-85-9sc-478179
sc-478179A
sc-478179B
10 mg
25 mg
100 mg
$203.00
$469.00
$1509.00
1
(0)

A potent Gs alpha subunit inhibitor, which could potentially affect Vmn1r160 signaling by inhibiting G-protein-mediated signal transduction.

YM 254890

568580-02-9sc-507356
1 mg
$510.00
(0)

A selective inhibitor of the Gq alpha subunit, potentially affecting Vmn1r160 function by altering GPCR-related pathways.

Pertussis Toxin (islet-activating protein)

70323-44-3sc-200837
50 µg
$451.00
3
(1)

An inhibitor of Gi alpha subunit, it could indirectly influence Vmn1r160 activity by modulating G-protein-coupled signaling.

XL413

1169562-71-3sc-474909
5 mg
$275.00
(0)

A CDC42 inhibitor, potentially affecting Vmn1r160 by altering actin cytoskeleton dynamics, which can influence GPCR signaling.

Gö 6983

133053-19-7sc-203432
sc-203432A
sc-203432B
1 mg
5 mg
10 mg
$105.00
$299.00
$474.00
15
(1)

A broad-spectrum protein kinase C inhibitor, it could indirectly influence Vmn1r160 activity by modulating PKC-mediated signaling pathways.

ATM/ATR Kinase Inhibitor Inhibitor

905973-89-9sc-202964
5 mg
$106.00
8
(1)

An inhibitor of Gq/11 alpha signaling, potentially affecting Vmn1r160 activity by modulating GPCR-related signal transduction.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

A PI3K inhibitor, it might indirectly influence Vmn1r160 through the PI3K/AKT signaling pathway.

PD 98059

167869-21-8sc-3532
sc-3532A
1 mg
5 mg
$40.00
$92.00
212
(2)

An MEK inhibitor, which could potentially affect Vmn1r160 signaling by influencing the MAPK/ERK pathway.

U-0126

109511-58-2sc-222395
sc-222395A
1 mg
5 mg
$64.00
$246.00
136
(2)

Another MEK inhibitor, potentially influencing Vmn1r160 by modulating the MAPK/ERK signaling pathway.

SB 203580

152121-47-6sc-3533
sc-3533A
1 mg
5 mg
$90.00
$349.00
284
(5)

A p38 MAPK inhibitor, potentially affecting Vmn1r160 by influencing stress-activated protein kinase pathways.